1:32:57CVS to pull cold medicines deemed ineffective by FDA
From the creator
CVS Health (CVS) announced on Thursday that it will begin to pull several common cold products after an advisory panel from the FDA ruled that the active ingredient, oral phenylephrine, was ineffective in those products. The ruling from the FDA does not apply to other common cold medicines like pseudoephedrine (Sudafed) or the nasal spray phenylephrine. Yahoo Finance Senior Reporter Anjalee Khemlani joins the Live show to break down the FDA ruling and what it means for the average consumer. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Yahoo Finance Plus: With a subscription to Yahoo Finance Plus get the tools you need to invest with confidence. Discover new opportunities with expert research and investment ideas backed by technical and fundamental analysis. Optimize your trades with advanced portfolio insights, fundamental analysis, enhanced charting, and more. To learn more about Yahoo Finance Plus please visit: https://yhoo.it/33jXYBp Connect with Yahoo Finance: Get the latest news: https://yhoo.it/2fGu5Bb Find Yahoo Finance on Facebook: http://bit.ly/2A9u5Zq Follow Yahoo Finance on Twitter: http://bit.ly/2LMgloP Follow Yahoo Financ
Published 2023-10-22 · Watch on YouTube ↗
Availability and playback restrictions are controlled by the original channel.





